Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Dimitra Sakellari has a total of 86 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Dual-Biomarker Oral-Rinse Testing for aMMP-8 and Calprotectin: A Potential Adjunctive Tool for Risk Stratification and Interdisciplinary Referral in Periodontitis and Type 2 Diabetes

    by Pietro Leone, Ismo T. Räisänen, Julie Toby Thomas, Pirjo Pärnänen, Sukumaran Anil, Andreas Grigoriadis, Dimitra Sakellari, Pierino di Silverio, Marco Evangelista, Timo Sorsa

    Periodontitis is a chronic, biofilm-induced inflammatory disease characterized by episodic connective tissue destruction and is epidemiologically associated with cardiometabolic conditions, notably type 2 diabetes (T2D) and cardiovascular disease (CVD). Conventional clinical signs do not reliably distinguish quiescent from actively progressing disease, which delays intervention and interdisciplinary referral. Chair-side point-of-care testing (POCT) of oral fluids offers a pragmatic, non-invasive adjunct for real-time assessment of disease activity, not only in dental but also in medical settings. This narrative review, reported in line with the Scale for the Assessment of Narrative Review Articles (SANRA), examines the clinical rationale and current evidence for oral-rinse POCT targeting active matrix metalloproteinase-8 (aMMP-8) and calprotectin. Oral-rinse aMMP-8 reflects disease-active collagenolysis and shows the more robust single-marker performance for periodontitis, whereas oral-fluid calprotectin, a neutrophil-derived S100A8/A9 protein, behaves as a predominantly local inflammatory signal and lacks validated oral-fluid reference ranges. Combining the two markers may add information beyond either alone when used in tandem as a complementary pair, but the supporting data are heterogeneous, largely exploratory, and hypothesis-generating. Dual-biomarker oral-rinse POCT is therefore best framed as a risk-stratification and referral aid rather than a stand-alone diagnostic, with combined interpretation potentially supported by AI technologies. Standardized pre-analytics, transparent threshold reporting, oral-fluid calprotectin reference values, and prospective multicenter validation are required before broad implementation.

  • Open Access

    Microbiological Effects of Laser-Assisted Non-Surgical Treatment of Peri-Implantitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

    by Chariklia Neophytou, Elpiniki Vlachodimou, Eleftherios G. Kaklamanos, Dimitra Sakellari, Konstantinos Papadimitriou

    Background: Peri-implantitis, a condition characterized by inflammation and progressive bone loss around dental implants, presents a significant challenge in contemporary dentistry. Conventional non-surgical treatments often fail to fully eliminate bacterial biofilms, particularly on complex implant surfaces. Laser therapies have emerged as potential adjuncts due to their antimicrobial and bio-modulatory properties. However, their microbiological effectiveness and suitability for individualized patient treatment planning remain unclear. Objective: Τhis study aims to systematically assess and synthesize the microbiological effects of various laser-assisted non-surgical treatments for peri-implantitis compared to conventional mechanical debridement. Methods: This systematic review and meta-analysis followed PRISMA guidelines and was registered in PROSPERO (CRD420251035354). Randomized controlled trials (RCTs) evaluating microbiological changes following laser-assisted non-surgical treatment of peri-implantitis, with a minimum follow-up of one month, were identified through searches in multiple databases and registries up to February 2025. The ncluded studies used lasers such as diode, Er: YAG, and photodynamic therapy (PDT) either alone or as adjuncts to mechanical debridement. Outcomes of interest included bacterial counts. Risk of bias was assessed using the RoB2 tool, and certainty of evidence was evaluated via GRADE. Quantitative synthesis used random-effects meta-analysis, with standardized mean differences (SMDs) calculated. Results: Eight RCTs involving 266 patients and 335 implants were included in the systematic review. Quantitative synthesis of three pathogens (counts of Fusobacterium nucleatum, P. gingivalis, T. denticola) across three studies displayed no statistically significant differences between laser and control groups at 3 and 6 months (p > 0.05 for all comparisons). When examining individual study findings, PDT, particularly in patients with diabetes or acute abscess, showed short-term reductions in red complex bacteria (e.g., Porphyromonas gingivalis and Treponema denticola). In contrast, diode and Er: YAG lasers demonstrated inconsistent or transient effects. The quality of evidence was rated as very low according to GRADE. Conclusions: Laser-assisted therapies, especially PDT, may provide targeted microbiological benefit in selected patient groups, supporting their adjunctive use within personalized treatment planning rather than as replacements for mechanical debridement, which remains the gold standard. Further high-quality RCTs incorporating well-defined patient risk profiles, such as systemic conditions and behavioral factors, and precision treatment algorithms are needed.


  • Open Access

    Quantitative real-time PCR detection of Porphyromonas gingivalis and Filifactor alocis in peri-implantitis

    by Ioannis Fragkioudakis, Georgios Konstantopoulos, Christine Kottaridi, Leonidas Batas, Dimitra Sakellari

    Introduction. Peri-implantitis is a prevalent and challenging complication in implant dentistry, primarily induced by biofilm-associated pathogens. Among these, Porphyromonas gingivalis and Filifactor alocis have emerged as key contributors, with evidence suggesting their potential synergistic role in exacerbating peri-implant inflammation and tissue destruction. Hypothesis/Gap Statement. While P. gingivalis is a well-characterized periopathogen, the specific role of F. alocis , alone or in combination with P. gingivalis , in peri-implantitis remains underexplored. This study addresses the gap in quantifying their presence in diseased versus healthy peri-implant sites. Aim. To assess the prevalence and microbial load of P. gingivalis and F. alocis in peri-implantitis and healthy peri-implant sites using quantitative real-time PCR (qPCR) and to investigate their correlation with clinical parameters. Methodology. This cross-sectional study included 110 participants: 52 diagnosed with peri-implantitis and 58 with healthy peri-implant tissues. Clinical examination recorded probing depth (PD), clinical attachment level (CAL) and bleeding on probing (BOP). Submucosal biofilm samples were collected and analysed using species-specific qPCR. Statistical analysis employed the Mann–Whitney U test for intergroup comparisons and Spearman’s rank correlation for associations between microbial levels and clinical indices. Results. Both P. gingivalis and F. alocis were significantly elevated in peri-implantitis sites compared to healthy controls. Mean P. gingivalis levels were 4.80×10⁶ ± 4.78×10⁶ copies µl −1 in peri-implantitis and 2.09×10³ ± 1.26×10³ copies µl −1 in healthy sites ( P F. alocis levels averaged 4.58×10⁵ ± 3.40×10⁵ copies µl −1 in peri-implantitis and 2.45×10³ ± 1.64×10³ copies µl −1 in healthy sites ( P P. gingivalis showed strong positive correlations with PD, CAL and BOP, while F. alocis correlated moderately with PD and CAL but not significantly with BOP. Conclusion. The significant elevation of P. gingivalis and F. alocis in peri-implantitis supports their potential synergistic involvement in disease pathogenesis. These findings underscore the need for antimicrobial strategies that target both organisms and disrupt their cooperative biofilm behaviour. Further research should clarify their pathogenic interplay and inform the development of precise therapeutic interventions.


  • Open Access

    Regular home use of dual-light photodynamic therapy as an adjunct to non-surgical periodontal treatment in smokers: a single-center randomized controlled clinical trial

    by Chrysoula Vakaki, Ioannis Fragkioudakis, Tommi Pätilä, Dimitra Sakellari

    Objectives: This RCT assessed the effectiveness of daily home-applied dual-light antimicrobial photodynamic therapy (aPDT) as an adjunct to non-surgical periodontal therapy (NSPT) in smokers with Stage III or IV periodontitis. Materials and methods: Sixty smokers were randomized to receive either NSPT alone (control) or NSPT with daily for four months at-home application of aPDT, prior to oral hygiene (test group). Clinical parameters—bleeding on probing (BoP), probing depth (PD), clinical attachment loss (CAL), gingival recession (REC), full-mouth plaque score (FMPS), and Turesky Index—were assessed at baseline, 2 weeks, 4 months, and 6 months. aMMP-8 levels and patient-reported outcomes were also recorded. Results: Both groups demonstrated significant improvements in BoP, PD, and CAL (p < 0.05), but no significant intergroup differences were observed. BoP reduction at 2 weeks favored the test group (− 33.60% vs − 23.94%; p = 0.056). BoP continued to decrease at 4 and 6 months, reaching 29.55 ± 19.86% in the control group and 27.57 ± 16.43% in the test group at 6 months. The difference in mean BoP between the two groups at 6 months was not statistically significant ( p = 0.680, Independent Samples Mann Whitney U Test). Plaque indices and aMMP-8 levels showed no significant differences. Compliance to dual-light aPDT averaged 77.7%; 72% of test participants were compliant. Greater compliance correlated with statistically significant improvements in mean values of all clinical parameters, whereas non-compliant patients presented with no changes (Related samples Friedman’s Two-Way Analysis). Patient-centered outcomes revealed positive feedback, with 84% of the patients willing to recommend the device and minor adverse effects. Conclusion: In smokers with advanced periodontitis, adjunctive home use of dual-light aPDT did not result in statistically significant improvements over NSPT alone in clinical parameters such as BoP, PD, or CAL. Future placebo-controlled, long-term clinical trials are warranted to further assess its potential role in supportive periodontal care. Clinical relevance: Within the limitations of this study, dual-light aPDT cannot be recommended as a superior adjunct to conventional treatment. Trial registration: ClinicalTrials.gov Identifier: NCT05962801.


  • Open Access

    Statistical Method for Dental Clinics for Determining Presence and Stage of Periodontitis with aMMP-8 Mouth Rinse Point-of-Care Test and Digital Reader

    by Miika Penttala, Ismo T. Räisänen, Dimitra Sakellari, Andreas Grigoriadis, Timo Sorsa

    Background/Objectives: This study proposes a framework for building a statistical prediction model for dental clinics to facilitate the diagnosis of periodontitis and its stages. The method is based on active-matrix metalloproteinase-8 (aMMP-8) mouth rinse point-of-care testing (POCT). Methods: A complete model was created within a three-step modeling scenario: (i) the first function differentiates healthy patients from those with periodontitis; (ii) the second function differentiates stage I and II patients from stage III patients; and (iii) the third function separates stage I and II patients from each other. The model was developed using logistic regression analysis, and the aMMP-8 POCT results utilized in the predictive functions were obtained from an Oralyzer digital reader. Sample data comprised 149 adult patients who visited dental clinics in Thessaloniki, Greece. Results: Patients without periodontitis were identified in 74.2% of cases (95% CI: 55.1–87.5%). Patients with periodontitis were revealed with a success rate of 94.1% (95% CI: 87.7–97.4%), and of these, the correct stage was determined in 71.2% of cases (95% CI: 61.7–79.2%). The complete model was tested on the same patient data from which it was formed. Conclusions: The results of the study showed that logistic regression can be used in the development of a model for dental clinics to reveal and stage periodontitis with sufficient accuracy. In the complete model created, aMMP-8 mouth rinse POCT results in ng/mL, visible plaque index (VPI), and the information on the patient’s missing teeth were statistically important factors in determining the presence and stage of periodontitis.


  • Open Access

    Using mouth rinse samples for screening periodontitis

    by M. Penttala, T. Sorsa, D. Sakellari, I. T. Räisänen


  • Open Access

    MMP ‐8 in Peri‐Implantitis: A Cross‐Sectional Study on Genetic Polymorphisms and Enzymatic Activation

    by Ioannis Fragkioudakis, Christine Kottaridi, Michalis Paraskeva, Dimitra Sakellari

    This graphical abstract illustrates a molecular cascade linking MMP-8 gene polymorphism (-799C/T), upregulated mRNA expression in peri-implant crevicular fluid, and elevated active MMP-8 protein levels. These factors were independently associated with peri-implantitis and may support molecular-based diagnostics.


  • Open Access

    Association of Single Nucleotide Polymorphisms in the Cyclooxygenase-2 (COX-2) Gene with Periodontal Disease—A Systematic Review with Meta-Analysis and Implications for Personalized Dentistry

    by Vasiliki Savva, Ioannis Fragkioudakis, Dimitra Sakellari

    Background: Genetic polymorphisms in the cyclooxygenase-2 (COX-2) gene may contribute to individual susceptibility to periodontal disease. A meta-analysis assessed the association between three COX-2 single-nucleotide polymorphisms (SNPs) namely, −765 G/C (rs20417), −1195 G/A (rs689466), and 8473 T/C (rs5275), and the risk of CP. Methods: Following the PRISMA 2020 guidelines, we conducted a comprehensive search of five electronic databases and additional sources. The eligible studies were observational (case–control or cohort) with genotypic data comparing individuals with periodontal disease and periodontally healthy controls. Methodological quality was assessed using the Newcastle–Ottawa Scale (NOS), and the certainty of evidence was evaluated via the GRADE framework. Pooled odds ratios (ORs) with 95% confidence intervals (CIs) were calculated under dominant genetic models. Results: Seven studies (n = 1467 participants) met the inclusion criteria. No eligible studies evaluated the 8473 T/C SNP. The meta-analysis of the −765 G/C variant revealed a significant association with periodontal disease (OR = 1.61; 95% CI: 1.12–2.32, p = 0.03; I2 = 0%). For the −1195 G/A variant, the pooled OR was 1.86 (95% CI: 1.00–3.43, p = 0.05; I2 = 35%), suggesting a borderline significant association. The certainty of evidence was graded as moderate for −765 G/C and low for −1195 G/A. Conclusions: The COX-2 −765 G/C polymorphism is significantly associated with increased CP risk, while the −1195 G/A variant shows a potential, though less certain, link. Larger, high-quality studies using standardized classifications are needed to confirm these associations.

  • Open Access

    Association of Single Nucleotide Polymorphisms in the Cyclooxygenase-2 (COX-2) Gene with Periodontal Disease: A Systematic Review with Meta-Analysis and Implications for Personalized Dentistry

    by Vasiliki Savva, Ioannis Fragkioudakis, Dimitra Sakellari

    Background: Periodontitis is a multifactorial inflammatory disease with complex interactions between microbial, environmental, and genetic factors. Cyclooxygenase-2 (COX-2), a key enzyme in prostaglandin synthesis, plays a significant role in periodontal inflammation. Single nucleotide polymorphisms (SNPs) in the COX-2 gene—particularly -765G/C (rs20417) and -1195G/A (rs689466)—have been investigated for their potential association with periodontitis, but results remain inconsistent across populations. Objective: This meta-analysis aimed to assess the association between twoCOX-2 gene polymorphisms (-765G/C and -1195G/A) and diagnosis of periodontitis, using aggregated data from observational studies across diverse populations. Methods: A systematic review and meta-analysis were conducted according to PRISMA 2020 guidelines. Seven case-control studies published between 2009 and 2023 were included, with data extracted on genotype distributions, odds ratios (ORs), and confidence intervals (CIs). Meta-analyses were performed under dominant genetic models. Heterogeneity and publication bias were evaluated using I² statistics and funnel plots, respectively. Results: The -765G/C polymorphism displayed a significant association with increased risk of CP (OR = 1.61, 95% CI: 1.12–2.32, p = 0.03), with no significant heterogeneity (I² = 0%). The -1195G/A variant demonstrated a borderline significant association (OR = 1.86, 95% CI: 1.00–3.43, p = 0.05), with moderate heterogeneity (I² = 35%). Funnel plot asymmetry suggested minimal publication bias for -765G/C, but possible small-study effects for -1195G/A. Conclusions: This meta-analysis supports a significant association between the COX-2 -765G/C polymorphism and presence of periodontitis, with suggestive evidence for the -1195G/A SNP.These findings suggest that COX-2 promoter polymorphisms may serve as potential biomarkers for individualized risk stratification and precision-based management of periodontitis.

  • Open Access

    Determination of the Stage of Periodontitis with 20 ng/mL Cut-Off aMMP-8 Mouth Rinse Test and Polynomial Functions in a Mobile Application

    by Miika Penttala, Timo Sorsa, Julie Toby Thomas, Andreas Grigoriadis, Dimitra Sakellari, Vaibhav Sahni, Shipra Gupta, Pirjo Pärnänen, Tommi Pätilä, Ismo T. Räisänen

    Background: We propose a framework for determining the stage of periodontitis in a personalized medicine context, building on our previously developed model for periodontitis detection. In this study, we improved the earlier model by incorporating additional components to form a comprehensive system for identifying both the presence and stage of periodontitis. Central to the home-use application is an active-matrix metalloproteinase-8 (aMMP-8) mouth rinse test (cut-off: 20 ng/mL), integrated with software delivered via a mobile application. Methods: First, using all the data, we modeled a single polynomial function to distinguish healthy and stage I periodontitis patients from stage II and III patients. Second, we used an already published periodontitis detection function to separate stage I patients from healthy patients. Third, one more function was created that divided stage II and III patients from each other. All functions were modeled by multiple logistic regression analysis from the patient data, which consisted of 149 adult patients visiting dental offices in Thessaloniki, Greece. Results: The complete model demonstrated a sensitivity of 95.8% (95% CI: 92.1–99.4%) and a specificity of 71.0% (95% CI: 55.0–86.9%) for detecting periodontitis. Among those identified with periodontitis, the correct stage was determined in 61.1% of cases, with stage-specific accuracies of 64.3% for stage I, 60.5% for stage II, and 60.9% for stage III. All testing was performed on patient data with which the complete model was formed. Conclusions: The results of this study showed that with sufficient data and using multiple logistic regression analysis, a model can be created to simultaneously identify the presence and stage of periodontitis. Overall, in the complete model generated, a mouth rinse aMMP-8 test result with a cut-off value of 20 ng/mL, Visible Plaque Index (VPI) and information of patient’s teeth number present were found to be important factors to determine the stage of periodontitis in a personalized medicine manner for everyone to use.